Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Novartis

Status and phase: Completed; Phase 2

Conditions: Renal Transplantation

Treatments: Drug: FTY720

Study type: Interventional

Funder types: Industry

Identifiers

NCT00239798

CFTY720A2218E1

Details and patient eligibility

About

This study will evaluate the safety and efficacy of FTY720 combined with cyclosporine and corticosteroids in patients receiving a kidney transplant.

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

• Patients who have completed the 12 Month visit of the Core trial either on or off study drug.
• Female capable of becoming pregnant are required to have a medically approved method of birth control until 3 Month after study medication was stopped.

Exclusion Criteria

• None

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind